Elena V. Semeleva

Elena V. Semeleva

Auto-generated profile, based on publicly available information

Elena V. Semeleva

Ogarev Mordovia State University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EBEkaterina Blinova
Ekaterina Blinova
ETEgor Turovsky
Egor Turovsky
EEElena Eliseikina
Elena Eliseikina
Aleksandra IgrunkovaAleksandra Igrunkova
Aleksandra Igrunkova
ESElena Semeleva
Elena Semeleva
DBDmitry Blinov
Dmitry Blinov
A non-surgical pharmacological approach to control cellular vitality and functionality during ischemic and/or reperfusion-induced phases of strokes remains extremely important. The synthesis of 2-ethyl-6-methyl-3-hydroxypyridinium gammalactone-2,3-dehydro-L-gulonate (3-EA) was performed using a topochemical reaction. The cell-protective effects of 3-EA were studied on a model of glutamate excitotoxicity (GluTox) and glucose-oxygen deprivation (OGD) in a culture of NMRI mice cortical cells. Ca2+ dynamics was studied using fluorescent bioimaging and a Fura-2 probe, cell viability was assessed using cytochemical staining with propidium iodide, and gene expression was assessed by a real-time polymerase chain reaction. The compound anti-ischemic efficacy in vivo was evaluated on a model of irreversible middle cerebral artery (MCA) occlusion in Sprague-Dawley male rats. Brain morphological changes and antioxidant capacity were assessed one week after the pathology onset. The severity of neurological disorder was evaluated dynamically. 3-EA suppressed cortical cell death in a dose-dependent manner under the excitotoxic effect of glutamate and ischemia/reoxygenation. Pre-incubation of cerebral cortex cells with 10–100 µM 3-EA led to significant stagnation in Ca2+ concentration in a cytosol ([Ca2+]i) of neurons and astrocytes suffering GluTox and OGD. Decreasing intracellular Ca2+ and establishing a lower [Ca2+]i baseline inhibited necrotic cell death in an acute experiment. The mechanism of 3-EA cytoprotective action involved changes in the baseline and ischemia/reoxygenation-induced expression of genes encoding anti-apoptotic proteins and proteins of the oxidative status; this led to inhibition of the late irreversible stages of apoptosis. Incubation of brain cortex cells with 3-EA induced an overexpression of the anti-apoptotic genes BCL-2, STAT3, and SOCS3, whereas the expression of genes regulating necrosis and inflammation (TRAIL, MLKL, Cas-1, Cas-3, IL-1β and TNFa) were suppressed. 3-EA 18.0 mg/kg intravenous daily administration for 7 days following MCA occlusion preserved rats’ cortex neuron population, decreased the severity of neurological deficit, and spared antioxidant capacity of damaged tissues. 3-EA demonstrated proven short-term anti-ischemic activity in vivo and in vitro, which can be associated with antioxidant activity and the ability to target necrotic and apoptotic death. The compound may be considered a potential neuroprotective molecule for further pre-clinical investigation.

7 December 2021 in Pharmacy & Pharmacology
Verified
Journal Article
Open access
PDF file
LBL. A. Balykova
L. A. Balykova
OROlga Radaev
Olga Radaev
KZK. Ya. Zaslavskaya
K. Ya. Zaslavskaya
YKYu. A. Kostina
Yu. A. Kostina
MIM. S. Iskandyarova
M. S. Iskandyarova
КЗК. Я. Заславская
К. Я. Заславская
In many ways, arterial hypertension and obesity determine the likelihood of a severe course and lethal outcomes in COVID-19. This fact justifies the expediency of an early use of drugs with a direct antiviral action, the analysis of their efficacy not only in the acute, but also in the postcovid period.The aimof the research was to analyze the outpatient cards and case histories of the COVID-19 patients to study the effect of the early (up to the 5thday after the onset of the first symptoms of the disease) use of the drug based on favipiravir, on the frequency of patients’ hospitalizations with arterial hypertension and obesity, as well as to determine the cytokine status characteristics of this patient category in the postcovid period.Materials and methods.“An open prospective comparative study of the “Areplivir®” (favipiravir) efficacy in the debut of COVID-19 in comorbid patients” was carried out in the Republic of Mordovia (the analysis of the hospitalizations frequency and blood levels of M-CSF, EPO in 218 patients, in terms of the use of the antiviral preparation).Results.According to the results of the analysis, it was found out that, despite the presence of comorbid conditions that increase the risk of developing a severe course of COVID-19, i.e. obesity and essential arterial hypertension, in the group of patients taking favipiravir, the need for hospitalization was twice as low (p < 0.05), in relation to the comparison group. The analysis of the cytokine status revealed that in the postcovid period, in the group that took the drug based on favipiravir at the outpatient stage, the average level of M-CSF was significantly lower (p> 0.05), and EPO was higher (p> 0.05) than in the patients from the group “without antiviral drugs at the outpatient stage”. Indirectly, according to the previously obtained data, that acts as a potential marker for reducing the risk of long-term cardiovascular complications of COVID-19.Conclusion.This study showed that an early prescription of favipiravir contributes to a decrease in the rate of COVID-19 patients’ hospitalization even against the background of concomitant hypertension and obesity, due to a decrease in the likelihood of moderate and severe courses of the disease, and also leads to an earlier objective and subjective recovery. The results demonstrated a high potential benefit of an early favipiravir use in the novel coronavirus infection and in the prevention of postcovid complications.

18 July 2024 in Research Results in Pharmacology
Verified
Journal Article
Open access
PDF file
RTRita M. Termulaeva
Rita M. Termulaeva
KBKonstantin Y. Belanov
Konstantin Y. Belanov
NBNatalya D. Bunyatyan
Natalya D. Bunyatyan
APAleksander S. Pirozhkov
Aleksander S. Pirozhkov
DTDmitrii E. Timoshkin
Dmitrii E. Timoshkin
DBDmitry Blinov
Dmitry Blinov
Introduction: Ischemic brain injury remains one of the main causes of disability and mortality worldwide. Protection of cellular population, depriving from oxygen supply and nutrients, is of extreme importance for further both clinical and health outcomes of timely implemented intravascular intervention. The aim: to assess anti-ischemic activity of 3-hydroxypyridine ascorbate in the in vitro and in vivo models of brain cell and tissue response to ischemia and reoxygenation. Materials and Methods: 3-hydroxypyridine ascorbate (laboratory code 3-EA) was assessed as chemical substance (purity 99.8%) diluted in sterile phosphate-buffered saline. Intracellular Ca2+ response to glutamate excitotoxicity (GluTox), ischemia and reoxygenation as well as cellular viability was evaluated on NMRI murine fresh cortical neuro-glial cell culture incubated with 2-EA by registering intracellular Fura-2 and propidium iodide fluorescence respectively. Expression of apoptosis regulating genes BCL-2, STAT3, SOCS3, inflammation regulating genes TRAIL, MLKL, Cas-1, Cas-3, IL-1β и TNFα, and genes MAO-A and MAO-B was determined by real-time PCR. The substance neuroprotection was studied in male Sprague-Dawley rats with intraluminal middle cerebral artery (MCA) occlusion/reperfusion treated with 18 mg/kg of 2-EA along with neurological deficiency evaluation and morphological assessment of brain sections. Results: Preincubation of cortical cells with 10-100 μM of 3-EA leads to inhibition of [Ca2+]i in cytosol of neurons and astrocytes under GluTox and oxygen-glucose deprivation (OGD) conditions. Reducing [Ca2+]i inhibits necrotic cell death in an acute experiment. Incubation of cerebral cortex cells with 3-EA leads to an overexpression of anti-apoptotic genes BCL-2, STAT3, SOCS3, along with downregulation of genes TRAIL, MLKL, Cas-1, Cas-3, IL-1β and TNFα. Intraperitoneal administration of 3-EA reduces the volume of necrotic areas, perinecrotic edema, cell damage, and neurological deficits in rats with MCA occlusion. Conclusion: 3-EA dose-dependently suppresses the death of cerebral cortex cells under the excitotoxic effects of glutamate and ischemia/reoxygenation. Cell-protective effect of 3-EA involves changes in the basal and ischemia/reoxygenation-induced expression of genes encoding anti-apoptotic proteins and oxidative status proteins, which leads to inhibition of the late irreversible stages of apoptosis. A course administration of 3-hydroxypyridine ascorbate at a dose of 18 mg/kg per day reduces the severity of damage both by preserving the population of neurons in the penumbra zone and by limiting the local stress response.

22 March 2022 in Лечащий врач
Verified
Journal Article
Closed access
ESE.V. Semeleva
E.V. Semeleva
OSO.A. Smirnova
O.A. Smirnova
EME.A. Mironova
E.A. Mironova
Due to insufficient oxygen supply to the fetus, which is called hypoxia, adverse changes occur in its body. In the total number of births, it is 10,5%. Fetal hypoxia is not an independent disease. It is a consequence of various pathological processes in the body of the mother, fetus and in the placenta. The health of a child is formed even during his intrauterine development, in this regard, fetal hypoxia at the present stage is an important medical and social issue, since it is directly related to the level of health of the population. The article analyzes the main factors contributing to the occurrence of hypoxia during pregnancy and childbirth. These can be diseases of the mother, such as: cardiovascular and pulmonary diseases, anemia, intoxication and others. It can also be a violation of the fetal-placental blood flow: gestosis, fetal prolongation, the risk of premature birth, pathology of the placenta and umbilical cord, various abnormalities of labor. The research was carried out on the basis of the Arzamas Maternity Hospital. Cases of development of fetal hypoxia, outcomes of pregnancies and childbirth in women with fetal hypoxia were analyzed. The aim of the study was to study the factors influencing the development of fetal hypoxia during pregnancy and childbirth in order to determine priority preventive measures to prevent this pathology in the city of Arzamas and Arzamas region. Retrospectively, 821 birth histories were analyzed – form No. 096/y, for the period 2017-2019, reporting data for the Arzamas maternity hospital. Based on the results obtained, in order to reduce fetal hypoxia, it is necessary to improve the quality of health improvement of the population at the pregravid stage, to allocate women with a complicated obstetric history to high-risk groups, to hospitalize women with pathology in the appropriate departments when their condition worsens and before childbirth. It is necessary to carry out psychoprophylactic preparation of pregnant women for childbirth, prohibit the work of women in hazardous work by law, organize physical culture breaks for women whose work is associated with physical inactivity.

30 March 2022 in Bulletin "Biomedicine and sociology"
Verified
Journal Article
Closed access
MYMazov Ya.A.
Mazov Ya.A.
EBEkaterina Blinova
Ekaterina Blinova
SESemeleva E.V.
Semeleva E.V.
EEEliseikina E.V.
Eliseikina E.V.
DEDagar E.A.
Dagar E.A.
YAYurochkina A.M.
Yurochkina A.M.
The safety and local anesthetic activity of the pharmaceutical composition LHT-15-13 containing a dimethylacetamide derivative, an antioxidant and a vasoconstrictor in rats with chronic periodontitis was studied in the work. White laboratory mice were used to determine acute toxicity with intravenous and subcutaneous administration of a 2% aqueous solution of LHT-15-32. In rats with experimental periodontitis, the threshold of pain sensitivity of the second upper molar was determined. The activity of oxidative stress and total antioxidant activity was determined in the mucous membrane of the gums of rats by the method of induced chemiluminescence. Local changes in periodontal tissues were assessed by quantitative enzyme immunoassay. The acute toxicity of the pharmaceutical composition when administered intravenously and subcutaneously was lower than that of the dimethylacetamide derivative with succinic acid LHT-600. LHT-15-13, when administered infraorbitally, caused deep anesthesia that lasted more than 70 minutes, activated the local antioxidant defense system and reduced the level of IL-1β in the gum tissue, caused tissue repair around the impacted upper molar in rats five days after injection. Thus, the pharmaceutical composition can be considered as an effective and safe agent for pain relief of the upper molars in periodontitis.

7 January 2023 in Лечащий врач
Verified
Journal Article
Closed access
EPE.V. Pligina
E.V. Pligina
ESE.V. Semeleva
E.V. Semeleva
Malignant neoplasms are one of the main causes of death in the world, which in 2020 ended the lives of about 10 million people. High mortality rates from malignant neoplasms are considered one of the negative trends in the dynamics of the health status of the Russian population. More than half of the deaths of the working-age population in Russia are due to diseases from the group of preventable deaths, and a third – to preventable causes, which depend on primary and secondary prevention, as well as the quality of medical care provided. The article presents data on the state of the oncological service in the Republic of Mordovia for 2019-2021. The purpose of the study is to analyze the organization of oncological care to the population of the Republic of Mordovia, the dynamics of morbidity and mortality of the population with malignant neoplasms. In this work, statistical data from Mordovia Statistics (the territorial body of the Federal State Statistics Service for the Republic of Mordovia) are used. The incidence of malignant neoplasms over a 3-year period decreased by 15.2% and amounted to 465.4 per 100 thousand population in 2021. The detection rate of patients in the early stages of malignant neoplasms (stage I-II) in the Republic of Mordovia in 2021 was 60.1%. There is a decrease in mortality to 170.0 per 100 thousand population, which is 0.1% lower than in 2019. The mortality rate within 1 year after the diagnosis of a malignant neoplasm in 2021 was 19.6%, which is 2% lower than in 2019. The proportion of patients registered at the dispensary for 5 years or more from the moment of diagnosis increased by 2% and amounted to 56.3% in 2021. The main task facing the oncological service is to reduce the mortality of the population from cancer pathology. The ways to solve it lie in the active development of the preventive direction of cancer control, close cooperation with the primary health care unit, in which primary medical care should be reoriented to the predominantly preventive direction.